Bionical Emas is a global Contract Research Organisation (CRO) business. We combine clinical development, early access program, and clinical trial supply capabilities to deliver a unique, seamless service for our international pharma and biotech clients. Our mission is to pioneer the way life-changing medicines are developed and accessed for patients around the world. Our range of services allows us to maximise access and generate evidence at every point along the drug development pathway. This enables us to simultaneously address the immediate and future needs of patients.